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Tail bud progenitor activity relies on a network comprising Gdf11, Lin28 
and Hox13 genes. 
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ABSTRACT 
During the trunk to tail transition axial progenitors relocate from the epiblast to 
the tail bud. Here, we show that this process entails a major regulatory switch, 
bringing tail bud progenitors under Gdf11 signaling control. Gdf11 mutant 
embryos have an increased number of such progenitors that favor neural 
differentiation routes, resulting in a dramatic expansion of the neural tube. 
Moreover, inhibition of Gdf11 signaling recovers the proliferation ability of these 
progenitors when cultured in vitro. Tail bud progenitor growth is independent of 
Oct4, relying instead on Lin28 activity. Gdf11 signaling eventually activates Hox 
genes of paralog group 13, which halt expansion of these progenitors, at least 
in part by down-regulating Lin28 genes. Our results uncover a genetic network 
involving Gdf11, Lin28 and Hox13 genes controlling axial progenitor activity in 
the tail bud. 
 
 
INTRODUCTION 
The vertebrate body is progressively laid down during embryonic development 
in an anterior to posterior sequence along its main axis. This process relies on 
the activity of distinct cell populations, collectively known as axial progenitors 
(Aires et al., 2018; Stern et al., 2006; Wilson et al., 2009). At early 
developmental stages, these progenitors are located in the epiblast, an 
epithelial layer that, as the embryo develops, gets restricted to its posterior end 
and becomes contiguous with the developing central nervous system 
(Psychoyos and Stern, 1996; Wilson and Beddington, 1996). These epiblast-
resident progenitors extend the post-cranial body axis all the way from the head 
through the trunk regions. However, as the epiblast recedes, axial progenitors 
relocate to the tail bud from where they further elongate the body by generating 
tail tissues (Aires et al., 2018; Wilson et al., 2009). In recent years, efforts have 
been directed towards both the characterization of these progenitors, as well as 
to understanding how their activity is regulated. Among the various subsets of 
progenitors, most of the attention has been drawn by the so-called neuro-
mesodermal progenitor (NMP) (Aires et al., 2018; Henrique et al., 2015; 
Steventon and Martinez Arias, 2017). Grafting experiments and clonal analyses 
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revealed their dual potency in the generation of both the spinal cord and 
paraxial mesoderm of the trunk and tail regions (Cambray and Wilson, 2007, 
2002; Tzouanacou et al., 2009). These cells are typically identified by the co-
expression of Sox2 and T(Brachyury) [Sox2+/T(Bra)+], neural and mesodermal 
markers respectively, on the basis of their expression profiles in regions known 
to contain NMPs (Cambray and Wilson, 2007; Wymeersch et al., 2016).  
Several signaling pathways and transcription factors have been shown to 
play relevant roles in the control of NMP growth, maintenance and 
differentiation along neural or mesodermal lineages. FGF and Wnt signaling are 
amongst the most important. Simultaneous inactivation of Fgf4 and Fgf8 in the 
mouse results in strong axial truncations due to a drastic reduction of axial 
progenitors (Boulet and Capecchi, 2012; Naiche et al., 2011). Likewise, Wnt3a 
inactivation also causes truncations at the trunk level, indicating its requirement 
for NMP activity (Greco et al., 1996; Takada et al., 1994). Wnt3a, however, also 
controls NMP differentiation, both by blocking neural determination and by 
promoting mesodermal fates together with Tbx6 (Garriock et al., 2015; Gouti et 
al., 2014; Jurberg et al., 2014; Martin and Kimelman, 2008; Takemoto et al., 
2011; Tsakiridis et al., 2014). T/Brachyury and the Cdx gene family are also 
essential for normal NMP function. Absence of these factors in the mouse 
truncates the embryo after the first few somites, which coincides with the 
beginning of NMP contribution to axial extension (Herrmann et al., 1990; Savory 
et al., 2011). 
Clonal analyses in the mouse indicate that NMPs are a continuous cell 
population throughout axial extension and are involved in the formation of the 
neural tube and paraxial mesoderm at all post-cranial axial levels (Tzouanacou 
et al., 2009). However, a variety of data indicate that the intrinsic properties of 
NMPs differ depending on their position along the anterior-posterior body axis. 
The most striking example is neural tube formation: while trunk NMPs make this 
structure by primary neurulation, their tail counterparts generate it by secondary 
neurulation (Schoenwolf and Smith, 1990). The fate of these two sections of the 
neural tube is different too, as most mature spinal cord derives from trunk 
neural tube whereas the secondary neural tube is mostly eliminated during the 
final stages of embryonic development (Nievelstein et al., 1993). Paraxial 
mesoderm formation and somitogenesis also have distinct mechanistic 
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requirements whether they derive from epiblast- or tail bud-residing NMPs. 
Indeed, it has been observed a differential requirement for the cycling behavior 
of Lfng expression (Shifley et al., 2008; Williams et al., 2014), as well as 
distinctive sensitivities to the presence of Hoxb6 activity (Casaca et al., 2016) at 
trunk or tail axial levels. 
The molecular bases underlying these differences are elusive. Oct4 
seems to be one of the factors involved in generating functional differences 
between epiblast and tail bud progenitors, as its activity is essential for trunk 
development but dispensable during tail-forming stages (Aires et al., 2016; 
DeVeale et al., 2013). It is therefore possible that equivalent factors exist to 
control tail bud NMP activity, although potential candidates for such roles have 
yet to be discovered. Genetic studies have identified some genes that seem to 
affect axial extension specifically at the level of the trunk to tail transition (Abu-
Abed et al., 2001; Ho et al., 2012; Sakai et al., 2001; Yamaguchi et al., 1999). 
However, inactivation of these factors often leads to strong axial truncations at 
that particular axial level, which complicates the study of their contribution to tail 
bud NMP activity. Due to the cumulative nature of embryonic development, 
severe truncations in the tail could as well derive from a critical role in the 
control of the trunk to tail transition, rather than from a direct involvement of the 
same factors in the regulation of tail bud-resident progenitors. Gdf11 seems to 
come out as an exception amongst these genes. Despite its central role in the 
control of the trunk to tail transition (Jurberg et al., 2013), its activity in this 
process is partially compensated by Gdf8 (McPherron et al., 2009), thus 
allowing the onset of tail development in Gdf11 mutant mice. Interestingly, tails 
of Gdf11 mutant fetuses display morphological differences to those of wild type 
embryos (Lee et al., 2010), suggesting an additional role for this signaling 
molecule in the regulation of tail bud progenitor activity. 
Here, we show that Gdf11 signaling is involved in the control of tail bud 
NMP activity. We found that the tail bud NMP population is expanded in Gdf11 
mutant embryos and that their differentiation becomes biased towards the 
production of neural tissues. This activity can also be seen in vitro, as tail bud 
progenitors proliferate considerably in culture when Gdf11 signaling is inhibited. 
Interestingly, this growth is independent of Oct4. Instead, our data indicate that 
Lin28 genes take a prominent role in the proliferation of axial progenitors after 
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the trunk to tail transition. Lin28 activity is then negatively regulated by Hox 
genes of the paralog group 13 (most specifically Hoxb13 and Hoxc13), which in 
the mouse are activated by Gdf11 signaling at the final stages of tail 
development. Our results indicate that epiblast and tail bud NMPs are under the 
control of different regulatory mechanisms and uncover a genetic network 
involving Gdf11, Lin28 and Hox13 genes regulating the activity of these 
progenitors after they have relocated to the tail bud. 
 
RESULTS 
Tail malformations in Gdf11 mutant embryos 
Skeletal preparations at embryonic day (E) 18.5 embryos showed clear 
differences in the post-sacral region of Gdf11 mutant fetuses when compared to 
wild type littermates (Fig. 1A). Despite some variation between specimens, tails 
of Gdf11-/- fetuses were always composed of vertebrae with fully developed 
neural arches accommodating neural tube until their very posterior end (Fig. 
1Ae, Af). This contrasted with the tail anatomy of wild type embryos, where 
caudal vertebrae lacked neural arches after their fourth element, coincident with 
the end of the neural tube (Fig. 1Ab, Ac). 
Abnormalities in Gdf11-/- tail development were already visible as early 
as E10.5. In mutant embryos, the tail did not show the typical tapering observed 
in wild type embryos (Fig. 1Bd) and frequently displayed tail bifurcations 
(Jurberg et al., 2013; and not shown). The transversal area at the level of the 
presomitic mesoderm (PSM) was 64% larger in Gdf11 mutants than in their wild 
type littermates (Fig. 1Bf and1C). Histological analyses (Fig. 1B) revealed 
equivalent tissue compositions in wild type and Gdf11-/- embryos, comprised of 
a dorso-medial neural tube, delimited laterally by paraxial mesoderm and 
ventrally by the notochord and tail endoderm. Gdf11 mutants also exhibited an 
ectopic ventral mass, which we had previously proposed might result from 
incomplete epiblast regression (Aires et al., 2016) (Fig.1Be, Bf, asterisk). 
However, despite their global similar histological structure, there were 
substantial quantitative divergences between wild type and Gdf11-/- embryos. 
The most striking difference was the dramatic increase in neural tube 
area, which was about three-fold larger in Gdf11 mutant embryos (Fig. 1B, D). 
Tail gut also occupied a broader area in Gdf11 mutants, although part of this 
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difference could stem from the invasion of the gut lumen by the ectopic ventral 
mass (Fig. 1Be, Bf). The presence of the ectopic pocket complicated precise 
quantification of the mesoderm, as this structure contains a significant 
mesenchymal component rich in mesodermal marker expression (Fig. S1). 
When this ectopic pocket was taken into account, the area occupied by 
mesodermal tissues was increased by about 25% in Gdf11-/-. However, when 
the ectopic mass was excluded from the analysis, the mesodermal tissue 
contribution, essentially represented by the paraxial mesoderm, was not 
significantly different in wild type and Gdf11 mutant embryos (Fig. 1D). These 
results indicate that the extended spinal cord observed in the tail of E18.5 
Gdf11 mutant embryos most likely derives from excessive formation of neural 
tissue during tail extension. Noteworthy, the different structural characteristics of 
the associated vertebrae do not appear to require formation of extra paraxial 
mesoderm, suggesting that they might have been produced during somite 
differentiation. 
 
Gdf11 mutant embryos contain expanded numbers of tail bud NMPs 
Axial extension at tail stage is powered by the activity of tail bud-resident NMPs 
(Henrique et al., 2015). It is thus possible that the observed structural defects in 
Gdf11 mutant tails originate from defective regulation of NMP number and/or 
fate. Fluorescence activated cell sorting (FACS) analyses of tail bud cells from 
E10.5 wild type and mutant embryos using antibodies against Sox2 and T(Bra) 
revealed complex two-dimensional patterns of continuous expression, rather 
than discreet populations (Fig. 2A). These patterns most probably reflect the 
process of lineage commitment, in which the NMPs [Sox2+/T (Bra)+] and their 
progeny gradually take a more neural (Sox2+) or mesodermal [T(Bra)+] fate as 
the tail elongates, without immediately loosing expression of the other marker 
gene. The patterns obtained from Gdf11-/- tails were consistently different to 
those of wild type embryos, including an increase in the total proportion of 
Sox2+/T(Bra)+ cells of about 23%, particularly regarding low-to-moderate Sox2 
and T expression levels (Fig. 2A, B). As NMPs might belong to the cell pool 
expressing moderate levels of both markers (Wymeersch et al., 2016), it is 
possible that this differential cell distribution in the tails of Gdf11 mutants 
reflects a genuine, although moderate, enrichment in tail NMPs. 
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The FACS profiles also revealed that, despite some variability, Gdf11 
mutant tail buds, contained almost twice as many Sox2+ cells, along with a 37% 
decrease in the proportion of T-expressing cells when compared with their wild 
type littermates (Fig. 2B). These results suggest a general bias in NMP 
differentiation favoring the production of neural derivatives in the absence of 
Gdf11 signaling. This is consistent with the proportionally larger neural tubes 
observed in Gdf11 mutant embryos.  
We further evaluated both the NMP content of wild type and Gdf11 
mutant embryos and their differentiation patterns using a genetic lineage-tracing 
scheme that combines the Cdx2-CreERT transgenic mice, which express the 
tamoxifen-inducible CreERT recombinase in axial progenitors throughout 
development (Jurberg et al., 2013; Jurberg et al., 2014), with the ROSA26r-β-
gal reporter (Soriano, 1999). Administering a single low tamoxifen dose to 
pregnant females carrying embryos with the ROSA26r- β-gal+/0::Cdx2-CreERT(+/0) 
genotype at E7.5 labels NMPs permanently with β-gal at the stage when these 
cells are engaged in neck/upper thoracic region development. Under such low 
dosage conditions, recombination is effective in a reduced number of cells for 
approximately 8 hours (Danielian et al., 1998) and, therefore, any β-gal-positive 
cell identified a few days later at more caudal embryonic levels must derive from 
this pulse of labeled NMPs. Successful NMP labeling was confirmed by the 
presence of β-gal-positive cells in neural and mesodermal derivatives all along 
the body axis caudal to the forelimb bud in E10.5 embryos (Fig. 3A). 
Importantly, we also found stained cells in the tail bud of these embryos, which 
included the chordo-neural hinge (Fig. 3Aa’’), consistent with NMPs being a 
continuous cell population as previously reported (Tzouanacou et al., 2009). 
The total number of β-gal-labeled cells per embryo showed some 
heterogeneity in both wild type and Gdf11-/- embryos, most likely due to 
variability in tamoxifen-induced Cre recombination. However, the general 
staining patterns, as well as the ratio of cells contributing to neural and 
mesodermal tissues were consistent amongst experiments. We detected 
equivalent ratios of labeled cells in sections at trunk levels of wild type and 
Gdf11 mutants with a similar distribution between neural and mesodermal 
derivatives (Fig. 3A, B). These results indicate that the absence of Gdf11 
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signaling did not produce a bias in the differentiation fate of these progenitors 
during trunk development. 
In contrast, while in the tails of Gdf11 mutants the contribution of β-gal-
labeled cells to neural tissues was similar to that observed at trunk regions, it 
was reduced by 60% in wild type embryos (Fig. 3C). A similar trend was 
observed in the mesodermal components of the tail, although not as strikingly, 
most particularly if the ectopic epithelial pocket is considered. Indeed, a 
considerable part of the β-gal+ cells accumulated in the ectopic ventral mass, 
including both its epithelial and mesenchymal components (Fig. 3Ab, Ab’’, D). 
This is consistent with the epithelial component of this mass being a remnant of 
the epiblast, still producing mesodermal derivatives that accumulate within the 
epithelial pocket (Aires et al., 2016). In addition, to the increased global 
numbers of labeled cells in the tails of Gdf11 mutant embryos, the proportion of 
these cells found in neural structures was consistently higher in the Gdf11-/- 
than in wild type tails (Fig. 3B-D). In particular, while in the tails of wild type 
embryos the frequency of labeled cells found in neural structures was similar to 
that observed at trunk levels (approximately 8%), in Gdf11-/- embryos about 
13% of the labeled cells was found in the neural tube (Fig. 3D). These results 
are in agreement with the three-fold increase of the neural tube area found in 
mutant embryonic tails and indicate an increased contribution of progenitors to 
neural lineages in the absence of Gdf11 signaling. Yet, a differential increase in 
proliferation rates could also contribute to the expanded tail bud neural 
derivatives in the absence of Gdf11 signaling. Indeed, we observed an 
approximate two-fold increase in proliferation specifically in the neural tubes of 
Gdf11 mutants (Fig. 3 E, F). Interestingly, we found a small reduction of 
proliferating cells in mesodermal compartments (including both paraxial 
mesoderm and ectopic ventral mass) of Gdf11 mutant tails. This could explain 
the decrease in the contribution of β-gal+ cells to the paraxial mesoderm, even if 
there are seemingly more mesodermal progenitors transitioning to the tail (Fig. 
3D). 
Together, these results show that Gdf11 signaling affects tail bud NMPs 
in at least two distinct ways. First, Gdf11 seems to control the overall number of 
those progenitors, as part of the reorganization of the progenitor pool during the 
trunk to tail transition and during extension throughout the tail. Secondly, it 
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appears to affect their fate decisions by restricting their contribution to neural 
lineages. 
 
Tail bud explants grow in vitro in the absence of Gdf11 signaling 
The experiments reported above indicate that NMP growth properties may be 
under different regulation before and after the trunk to tail transition. Axial 
progenitors have been shown to lose their ability to grow in vitro at around E9.0, 
approximately coincident with their relocation to the tail bud (Osorno et al., 
2012). As the NMP tail bud population seemed to be expanded in Gdf11 mutant 
embryos, we hypothesized that Gdf11 signaling could be involved in arresting 
the growth of these cells in vitro. We tested this by comparing the growth of tail 
bud cells explanted from either wild type or Gdf11 mutant E10.5 embryos in 
culture conditions known to facilitate NMP production (Gouti et al., 2014). Cells 
obtained from wild type embryos were maintained in culture for several days 
and were able to withstand at least three passages. However these cells 
expanded slowly, with an average population doubling time (PDT) of 57h, until 
they gradually lost the ability to grow and eventually died within 15 to 18 days 
(Fig. 4A), consistent with previously published observations (Osorno et al., 
2012). 
In contrast, cells derived from Gdf11-/- embryos had a decreased PDT 
(≈29h) and sustained steady growth during several passages, although the 
population doubling levels were somewhat variable amongst experiments (Fig. 
4A). This variation could reflect heterogeneity of the explanted cells and/or 
partial replacement of the Gdf11 activity by Gdf8 or components of the growth 
media. To block such potential interferences, we incubated Gdf11 mutant tail 
bud cells in the presence of SB431542, an inhibitor of Alk5 (also known as 
TgfβRI), which is the type I receptor mediating Gdf11 activity (Andersson et al., 
2006). This treatment not only increased the overall growth capacity of the cells 
by decreasing the PDT to ≈18h, but also reduced the experimental variability 
(Fig. 4A). Interestingly, SB431542 could rescue the growth ability of wild type 
tail bud cells to levels similar to those obtained with Gdf11 mutant cells cultured 
under similar conditions (PDT ≈21h) (Fig. 4A). These results are consistent with 
our in vivo observations, supporting a role for Gdf11 signaling in the control of 
the growth properties of tail bud-derived progenitors. 
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 Gene expression analyses for neural and mesodermal marker genes at 
3, 6 and 9 days post-culture confirmed that the absence of Gdf11 signaling 
promotes neural fates in vitro. Gdf11-/- tail buds, as well as mutant and wild type 
explants cultured with SB431542 expressed Sox2, Tubulin and Nestin (Fig. 4B, 
C and Fig.S2A, B), while these genes were down regulated or even not 
detected in wild type cultures. Conversely, mesodermal markers such as T 
(Bra) and Mesogenin1 were activated in wild type cells before they were 
switched off (Fig. 4B and Fig S2A). Interestingly, we found some cells co-
expressing Sox2 and T (Bra) at day 3 post-plating, particularly in Gdf11-
deficient conditions. However these cells quickly disappeared in the following 
passage, which agrees with the transitory nature of Sox2+/T (Bra)+ cells in 
culture (Gouti et al., 2014). Tbx6 expression, however, stood out amongst the 
tested mesodermal markers, as it showed slight and variable increase in the 
absence of Gdf11 signaling. In particular, Tbx6 was frequently observed in 
combination with Sox2 (Fig. 4B and Fig. S2C). This behavior might be related to 
an increased and transitory presence of tail bud NMPs in those cultures, since 
Tbx6 expression has been recently linked to tail bud NMPs (Javali et al., 2017). 
Together, these results suggest that in vitro tail bud explant cultures can mimic 
the effects of the absence of Gdf11 signaling we had observed in vivo. 
It has been shown that Oct4 can recover tail bud cell growth in vitro 
(Osorno et al., 2012), thus opening the possibility that inhibition of Gdf11 
signaling might produce de novo Oct4 activation in explanted cells, which in turn 
would promote their proliferation. However, we consider it unlikely, as we were 
unable to detect Oct4 expression in cultured cells (not shown). This observation 
suggests that tail bud cell proliferation must be regulated by mechanisms 
different from those operating on their epiblast-located counterparts, thus 
supporting the hypothesis that epiblast and tail bud NMPs are functionally 
distinct cell populations. 
 
Differential gene expression in Gdf11 mutant tails 
To assess how Gdf11 regulates tail bud NMP activity, we compared the RNA 
profiles of E10.5 wild type and Gdf11-/- tail buds by RNA-seq (Table S1). Gene 
ontology analysis for the top 88 genes that showed an increase of two or more 
fold in Gdf11-/- tails revealed substantial enrichment in genes involved in the 
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positive regulation of neuroblast development, neural cell migration, and kidney 
and limb development (Fig. S3A). Induction of both hind limbs and kidneys is 
closely associated with the region of the trunk to tail transition; therefore, the 
increased expression levels of genes related to these structures might be linked 
to the delay of this transition in Gdf11-/- embryos. Expression of factors involved 
in neural tube development and neural stem cell function were also up 
regulated in mutant embryos (Fig. 5A), consistent with their considerably larger 
neural tubes. 
Conversely, T (Bra), Tbx6 and Mesogenin1, commonly associated with 
mesodermal fates, were found down-regulated in these embryos (Fig. 5A, Fig. 
S3B). In situ hybridization analyses confirmed that in Gdf11-/- embryos, 
expression of these genes was reduced in the tail PSM, although their 
expression was still significant in the ectopic mass (Fig. S1). These results 
corroborate the NMP differentiation bias towards neural fates in the tail bud of 
Gdf11 mutant embryos, as already indicated by the FACS analyses and cell 
tracing experiments. It should be noted that despite its reduction in size, the 
PSM of Gdf11 mutant embryos preserved cycling activity (Fig. S1D), which is 
consistent with the production of individual vertebral units in the area caudal to 
the hind limbs. Interestingly, expression of Sox10, a gene associated with 
neural crest (Southard-Smith et al., 1998), was substantially higher in the Gdf11 
mutant dataset (Fig. 5A). In situ hybridization analyses showed that in the 
mutant embryos neural crest cell production covered almost the whole extent of 
the neural tube, in contrast with wild type embryos that lacked neural crest 
derivatives in most of their tail region (Fig. S3D). 
Out of these many differentially expressed genes (Fig. 5A), we 
particularly focused on the Lin28 genes, which code for RNA binding proteins 
involved in the maturation of several miRNAs, most prominently those of the let-
7 family (Viswanathan and Daley, 2010). These genes are interesting in the 
context of axial progenitor activity due to their association with the expansion of 
neural progenitors (Yang et al., 2015) and their link to a metabolic pathway that 
seems to play a relevant role in the expansion of tail bud progenitors (Oginuma 
et al., 2017; Zhu et al., 2011). Lin28a is expressed in the tail bud of E10.5 wild 
type embryos, particularly in the progenitor-residing areas, the caudal part of 
the neural tube and adjacent ventral mesoderm (Fig. 5Ba and Fig. S3Ea). One 
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day later, this gene becomes strongly down-regulated in the entire tail region 
(Fig. 5Bi and Fig. S3Ec). Lin28a expression in E10.5 Gdf11 mutants grossly 
resembled the pattern observed in wild type embryos, although the signal in the 
tail bud appeared stronger (Fig. 5Be and Fig. S3Eb). This was consistent with 
RNA-seq data, which showed an almost two-fold increase in expression relative 
to wild type tail buds (Fig. 5A). However, Lin28a remained robustly expressed in 
the tails of E11.5 Gdf11-/- embryos (Fig. 5Bm and Fig. S3Ed), indicating that 
Lin28a may participate in the tail phenotype exhibited by Gdf11 mutants. 
Equivalent patterns were observed with Lin28b (Fig. 5Bb, Bf, Bj, Bn). Notably, 
expression of both Lin28a and Lin28b was distinctly strong in Gdf11 mutant 
embryos, in their posterior neural tube and in the progenitor-containing region of 
the tail bud at E11.5, which contrasted with the absence of any detectable 
transcripts for these genes in the same regions of wild type embryos at this 
developmental stage. 
We then tested the effect of sustained Lin28 gene expression in axial 
progenitors by expressing Lin28a and Lin28b, either alone or in combination, 
using the Cdx2 enhancer. At E18.5, transgenic fetuses had longer tails, with a 
significant increase in number of caudal vertebrae (Fig. 5C). In addition, 
expression analyses at E13.5, which corresponds to the final stages of axial 
extension, showed that T (Bra) and Sox2 not only were still present in Cdx2-
Lin28a transgenic tail buds, but had expanded expression domains (Fig. 5E). 
Interestingly, some of these Cdx2-Lin28a embryos displayed bifurcated tail 
buds that likely reflected an excessive tail tissue production (Fig. 5Eb, Ee). 
 
Hox13 genes act downstream of Gdf11 
RNA-seq datasets also revealed that Hoxb13 and Hoxc13 were the most 
strongly down-regulated genes in Gdf11-/- tail buds (Fig. 5A). This differential 
expression was confirmed by in situ hybridization (Fig. 5Bc, Bd, Bg, Bh, Bk, Bl, 
Bo, Bp). At E10.5, we could not detect any Hoxb13 and only a faint Hoxc13 
expression in Gdf11-/- tails, whereas only residual expression was scored at 
E11.5. The tails of both Hoxb13 and Hoxc13 mutant embryos share some of the 
abnormal characteristics found in Gdf11 mutants, although milder in intensity. In 
particular, Hoxb13 mutants have thicker, caudally-elongated neural tubes and 
supernumerary dorsal root ganglia, together with the presence of lateral 
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processes in a larger number of caudal vertebrae (Economides et al., 2003). 
Hoxc13 mutants have not been characterized in so much detail but they also 
contain a larger number of caudal vertebrae with lateral processes (Godwin and 
Capecchi, 1998). It is thus possible that these genes are downstream mediators 
of the Gdf11 activity promoting axial termination. 
We thus examined the effect of premature expression of either Hoxb13 
or Hoxc13 in axial progenitors. Both Cdx2-Hoxb13 and Cdx2-Hoxc13 transgenic 
embryos showed strong underdevelopment of axial structures derived from the 
tail bud (Fig. 6A-C), which is consistent with previously published data (Young 
et al., 2009). Molecular analyses of the transgenic embryos at mid-gestation 
indicated disorganized mesoderm and undersized neural tubes in the tail 
region, as revealed by T (Bra) and Sox2 in situ hybridization, respectively (Fig. 
6D-I). In addition, we observed a significant decrease in cell proliferation and an 
increase in apoptotic figures in the posterior end of the neural tube in Cdx2-
Hoxb13 transgenic embryos (Fig. 6O-S). This suggests a specific role for 
Hoxb13 during tail development, by restricting cell proliferation and regulating 
cell death in tail tissues, particularly in the neural tube. 
Surprisingly, even in those Hox13 transgenic embryos showing very 
strong axial malformations, these alterations were mostly restricted to the tail 
and only minor (if any) malformations were scored in more anterior embryonic 
areas despite a strong Cdx2 enhancer activity in these regions (Fig. 6 A-L). This 
observation suggests that trunk axial progenitors may be differentially affected 
by the activity of these Hox genes, once again raising the matter of potential 
differences existing between trunk and tail axial progenitors. 
 
Functional interaction between Lin28 and Hox13 genes 
A close evaluation of Lin28 and Hoxb13 and Hoxc13 expression patterns in the 
embryonic tail indicated that they are to some extent inversely correlated 
(compare Fig. 5Bi and Bk, inlets), suggesting a potential functional association. 
Consistent with this hypothesis, expression analyses of E10.5 Cdx2-Hoxb13 
and Cdx2-Hoxc13 transgenic embryos revealed strong Lin28a down-regulation 
(Fig. 6J-L). Since embryos lacking the whole HoxC cluster (HoxCΔ) display tail 
alterations similar to those observed with the Hoxc13 mutant mice (Godwin and 
Capecchi, 1998; Suemori and Noguchi, 2000) and also to avoid compensation 
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by other genes from the HoxC cluster, we used them as a proxy for Hoxc13 
inactivation in this posterior area. In situ hybridization analyses at E10.5 
revealed a slight but consistent increase in Lin28a expression in HoxCΔ when 
compared to wild type littermates (Fig. 6M, N), further supporting a genetic 
interaction between Hox13 and Lin28 genes. 
We also observed an regulated expression of both Lin28a and Lin28b in 
explanted tail bud progenitors grown under Gdf11-inhibiting conditions, but not 
in wild type cells grown in the absence of SB431542 (Fig. 7A, B). The inverse 
pattern was observed for Hoxb13 and Hoxc13 expression, which was activated 
in wild type cells cultured in the absence of the drug but barely detectable in 
explanted cells lacking active Gdf11 signaling (Fig. 7A, B and Fig. S4). These 
results further support a functional interaction between Lin28 and Hox13 genes 
in tail bud progenitors and a key role for Gdf11 signaling in the modulation of 
this interaction, perhaps through the control of Hox13 activation. In addition, 
they indicate that the explanted cells conserve, to a significant extent, most of 
their in vivo properties, particularly regarding the control of cell proliferation. 
 
DISCUSSION 
In this work, we propose that the functional characteristics of tail bud axial 
progenitors and the genetic mechanisms involved in their regulation are 
different from those operating in their epiblast-resident counterparts. Our data 
indicates that a genetic network involving Gdf11, Lin28 and Hox13 genes (most 
particularly those of the HoxB and HoxC clusters) is at the core of the 
mechanisms regulating tail bud NMP activity. This contrasts with the 
dependence of epiblast axial progenitors on Oct4 (Aires et al., 2016; DeVeale et 
al., 2013). This regulatory switch might underlie the differences between trunk 
and tail NMPs in what concerns both their intrinsic behavior and the fate of their 
derivatives. The most relevant of those differences involves the neural tube, 
formed by primary neurulation at trunk levels and by secondary neurulation in 
the tail (Schoenwolf and Smith, 1990). In the newborn, the spinal cord mostly 
derives from the primary neural tube, whereas the secondary neural tube is 
largely eliminated at later developmental stages, contributing very little to adult 
tissues. Thus, this variation in the mode of neural tube development is not just 
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purely conceptual, but might actually reflect important underlying differences 
that are then translated specifically into the neural tube fate. 
The tail bud regulatory network might control development of the tail axial 
progenitors at different stages of their activity during the morphogenesis of tail 
structures, in which Lin28 and Hox13 genes would be mostly associated with 
activating and repressing processes, respectively. This way, Gdf11 signaling 
would potentially function as a coordinating unit by controlling the timing of the 
trunk to tail transition and, therefore, the temporal and mechanistic shift from the 
molecular networks controlling epiblast-residing progenitors to the ones 
regulating tail bud-dependent axial extension. 
 
Gdf11 as a regulator of NMP reorganization and expansion during the 
trunk to tail transition 
The first stage in this mechanistic shift might involve regulating the expansion of 
the tail bud NMPs themselves. The transient nature of these progenitors 
complicates proper estimation of this variable. However, a variety of 
observations provide indirect support for this possibility. In particular, forced 
Lin28 expression in the progenitor-containing region of the embryo consistently 
increased the number of tail vertebrae, suggesting a positive effect of these 
genes on tail bud NMP activity. Conversely, premature expression of Hoxb13 or 
Hoxc13 restricted NMP expansion, leading to strong axial truncations. The 
increased number of caudal vertebrae in Hoxb13 mutant embryos (Economides 
et al., 2003) is also consistent with negative regulation of NMP expansion or 
maintenance by Hox13 genes. Finally, the tail bud of Gdf11-/- embryos, where 
Lin28 activity prevails over Hox13 genes, contain more Sox2+/T (Bra)+ cells, 
which could reflect enrichment in NMPs. 
Interestingly, premature expression of Hoxb13 and Hoxc13 in axial 
progenitors interfered strongly with tail development but had negligible effects 
on trunk extension, despite robust activity at both axial levels of the Cdx2 
enhancer used in those transgenic experiments. These observations indicate 
that although NMPs seem to be a continuous cell population throughout the 
main body axis (Tzouanacou et al., 2009), their functional properties undergo 
major changes during the process of relocation into the tail bud. 
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Gdf11 controls neural progenitors during axial extension of the tail 
A variety of data indicate that the Gdf11/Lin28/Hox13 network also plays a 
prominent role in the development of the tail-associated neural tube. Cell tracing 
experiments revealed a higher relative contribution of labeled cells to neural 
tissues in the tail region of Gdf11 mutant embryos both when compared to the 
same region of their wild type littermates and, most importantly, to trunk areas 
of the same embryo. The observed increase in the mitotic numbers in the tail 
neural tube of Gdf11 mutant embryos suggests that differential expansion of the 
neural progenitors might contribute to this effect. As a consequence, Gdf11 
mutant embryos contained enlarged spinal cords, already evident at early 
stages of tail development. The remarkable growth capacity of tail bud cell 
explants grown in vitro under Gdf11-deficient conditions, together with their 
differentiation bias towards neural fates, is consistent with a substantial 
expansion of a neural progenitor compartment in those cultures. An increase in 
neural progenitors in Gdf11 mutant embryos has also been observed during 
differentiation processes both in the spinal cord (Shi and Liu, 2011) and in the 
olfactory epithelium (Gokoffski et al., 2011), indicating a general role for Gdf11 
in the control of the neural progenitor pool size during development. 
Despite this conservation, the mechanisms associated with Gdf11 
activity might differ in the various embryonic areas. In the particular case of tail 
extension it most likely includes control of Lin28 and Hox13 activities. Lin28 
genes, which have been shown to be involved in neural progenitor expansion 
(Yang et al., 2015), are very highly expressed both in the enlarged tail neural 
tube of Gdf11 mutant embryos and in cultured tail bud explants incubated under 
Gdf11 inhibiting conditions. This expression contrasts with the normal dynamics 
of Lin28 expression in the developing tail, where it becomes progressively 
reduced coincident with the decrease in tail neural tube size. Lin28 expression 
levels are also very low or absent in tail bud cell explants cultured under Gdf11-
permissive conditions. The increased Sox2 expression in the posterior end of 
the tail of E13.5 Cdx2-Lin28a transgenic embryos provides additional support 
for the competence of Lin28 genes to promote neural fates in the tail bud. In 
addition, the inverse correlation between Hox13 and Lin28 gene expression 
both in vivo and in vitro suggests that the progressive reduction in Lin28 
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expression observed in tail tissues of wild type embryos can likely result from 
the activation of Hoxb13 and Hoxc13 genes. 
The specific regulatory network operating in tail tissues might account for 
one of the hallmarks of the secondary neural tube, namely its selective removal 
during morphogenesis of the final mature tail structures (Nievelstein et al., 
1993). Hox13 genes would play a critical role in this process. This idea is 
supported by the observation that the axial level where these Hox genes (most 
particularly Hoxb13 and Hoxc13) become activated in mouse embryos fits well 
with the region of the neural tube fated to disappear. The caudally extended 
spinal cord observed in Hoxb13 mutant embryos, which was proposed to derive 
from an incomplete elimination of the secondary neural tube (Economides et al., 
2003), is also consistent with this hypothesis. A possible functional redundancy 
between Hox13 genes might explain the relatively mild neural phenotype in the 
tail of the Hoxb13 mutants, similarly to what has been observed for other Hox 
paralog groups (Mallo et al., 2010). Hoxc13 could be among the best 
candidates for a possible redundant function given its expression pattern and 
the observation that the mutants have additional caudal vertebrae with lateral 
processes (Godwin and Capecchi, 1998), which could represent a caudal 
extension of the tail neural tube. Direct evaluation of this hypothesis will require 
generating the double Hoxb13/Hoxc13 mutant, which has so far not been 
reported. However, Gdf11 mutant embryos, in which these two genes are 
almost completely silent, fail to resorb the embryonic tail neural tube, producing 
mature structures in the newborn. Although it is not possible to be sure about 
the actual contribution of absent Hox13 gene expression to this phenotype, 
considering the strong effect that premature Hox13 expression has on the 
proliferation and apoptosis in Sox2-positive areas of the tail neural tube, it is 
likely that Hox13 genes indeed play a substantial role in the tail spinal cord 
phenotype of Gdf11 mutant embryos. 
Hox13 gene activity in the tail neural tube might thus include two 
sequential processes. It would first limit spinal cord expansion in the areas fated 
to be resorbed. This effect might be mediated through the control of Lin28 gene 
expression, as it is strongly reduced in the Hoxb13 and Hoxc13-expressing 
areas of the tail neural tube and boosted in Gdf11 mutant embryos, which fail to 
activate Hoxb13/Hoxc13 expression. An inverse correlation between Hox13 and 
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Lin28 gene expression was also evident in cultured tail bud cells, also fitting 
with their growth properties. Whether Lin28 regulation by Hox13 proteins is 
direct or indirect remains to be determined. 
Later in development, Hox13 genes might activate apoptosis, eventually 
leading to tail neural tube elimination. This is supported by the reduced cell 
death observed in persistent areas of the tail spinal cord of Hoxb13 mutant 
embryos (Economides et al., 2003). In addition, we observed an increase of 
apoptotic figures in the tail neural tube of Cdx2-Hoxb13 embryos. This second 
Hox13 activity might actually explain the absence of larger neural tubes in 
Cdx2-Lin28 transgenics: as the Cdx2 enhancer is active only in progenitor-
containing areas, with very little extension into the neural tube, any extra spinal 
cord resulting from the activated progenitors would be subsequently eliminated 
by Hox13 gene activity as part of the normal physiology of tail development. 
 
Regulation of Lin28 and Hox13 expression in the tail 
The observed expression dynamics of the Lin28 genes indicates a change in 
their regulation coincident with the start of tail development. In particular, while 
their expression is not restricted to tail tissues, their transcripts only accumulate 
specifically in the tail region of Gdf11 mutant embryos. The mechanism by 
which this regulation is carried out is not known but it is most likely related to the 
changes that the progenitors undergo during the trunk to tail transition. The 
expression pattern observed in the Gdf11 embryos actually suggests that Lin28 
gene regulation undergoes a major change in their regulation when NMPs move 
from the epiblast to the tail bud. Gdf11 signaling might play a role in this 
process, as it is one of the key drivers of the trunk to tail transition [with partial 
redundancy of Gdf8 (McPherron et al., 2009)]. However, regardless of the role 
Gdf11 might play in this process, it is most likely permissive, facilitating the 
necessary changes in the cell biology of the progenitor cells intrinsic to their 
relocation into the tail bud. 
Gdf11 signaling might play a more direct role in the control of Hox13 
gene expression. Indeed, this signaling pathway has already been shown to 
play a key role in the activation of posterior Hox genes (10 to 13 paralogs) 
(Deschamps and Duboule, 2017; Gaunt et al., 2013; Jurberg et al., 2013; Mallo, 
2018). 
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Lin28 activity in the tail bud progenitors 
It has been recently reported that aerobic glycolysis is essential for the activity 
of tail bud progenitors (Oginuma et al., 2017). Interestingly, Lin28 genes have 
been implicated in the regulation of glucose metabolism, an activity that has 
been suggested to be mechanistically linked to their capacity to stimulate 
cancer progression by triggering the Warburg effect (Zhu et al., 2011). It is thus 
possible that promotion of aerobic glycolysis could be part of the mechanism by 
which Lin28 genes control expansion and/or maintenance of tail bud axial 
progenitors. In this regard, several genes associated with this metabolic 
pathway seem to exhibit higher expression scores in Gdf11 mutants than in wild 
type controls in our tail bud RNA-seq datasets (Fig. S3C). Although this is 
clearly too preliminary, it still suggests that the Lin28/metabolic connection in tail 
bud progenitors might be worth exploring in further detail. Similarly, it will be 
important to understand whether Lin28 activity in tail bud axial progenitors is 
functionally linked to the let-7 miRNA family, as it does in other biological 
contexts (Zhu et al., 2011), or it follows alternative pathways. 
 
The Gdf11Lin28/Hox13 network and tail size variability. 
Quantitative differences within the Gdf11/Lin28/Hox13 network might 
account for the tail size variability observed among vertebrate species. In 
particular, the timing of Hox13 gene activation relative to the onset of the Lin28-
dependent NMP phase might play a relevant role in this process. Another 
important parameter in tail length determination might result from the relative 
intensity of each of the components’ activity in this network, either as a result of 
their expression level or of the intrinsic functional strength of their gene 
products. Experimental data gives support to this hypothesis. For instance, 
anticipating Hox13 expression in transgenic mouse embryos shortened 
considerably their tail. Conversely, reducing the Hox13 dosage or increasing the 
Lin28 expression levels in the tail significantly extended its length. Therefore, it 
will be important to test these parameters in embryos of vertebrate species with 
different tail sizes. Interestingly, in chicken – a shot tailed species -, Hoxb13 
expression encompasses most of the tail bud (Denans et al., 2015). Full 
understanding of the mechanisms regulating tail size will require not only 
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identifying how Gdf11 signaling controls Lin28 and Hox13 activities, but also the 
pathways downstream of Lin28 and Hox13 genes.  
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STAR METHODS 
 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed 
to and will be fulfilled by the Lead Contact, (mallo@igc.gulbenkian.pt). There 
are no specific restrictions for the use of materials within this manuscript. 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Gdf11 mutant embryos were produced from intercrosses between Gdf11+/- mice 
(McPherron et al., 1999) (MGI Cat# 3589479, RRID:MGI:3589479). The HoxCΔ 
mutants (MGI:3640654) have been previously described (Suemori and Noguchi, 
2000). For lineage tracing experiments, Gdf11 heterozygous males containing 
the Cdx2-CreERT transgene (Gdf11+/-::Cdx2-CreERT+/+) (Jurberg et al., 2013) 
were crossed with Gdf11 heterozygous females that additionally carried a 
knock-in Cre-inducible LacZ allele in the ROSA26 locus  [FVB.129S4(B6)-
Gt(ROSA)26Sor<tm1Sor>/J, stock No: 09427, Jackson] (Soriano, 1999) (Gdf11+/-
::ROSA26r-β-gal+/0 mice), to generate Gdf11-/-::Cdx2- CreERT+/0::ROSA26r-β-
gal+/0 embryos. To generate the transgenic embryos and fetuses expressing the 
Hoxb13, Hoxc13, Lin28a and Lin28b genes, constructs were prepared by 
cloning the relevant cDNAs under the control of the Cdx2 enhancer (Benahmed 
et al., 2008) and the SV40 polyadenylation signal. The Cdx2-HoxC13 
transgenic construct has been previously described (Young et al., 2009). The 
DNA constructs were liberated from vector sequences, gel purified and used to 
produce transgenic embryos by pronuclear injection according to standard 
procedures (Hogan et al., 1994). All primers used to generate the cDNAs can 
be found in the Key Resource Table. 
 
Genotyping 
Pups and adult mice were genotyped from tail biopsies. Samples were 
incubated overnight at 55º C in PBND buffer (50 mM KCl, 10 mM Tris-HCl pH 
8.3, 2.5 mM MgCl2, 0.1 mg/ml gelatin, 0.45% Nonidet P40 (NP40), 0.45% 
Tween 20) containing 200 µg/ml proteinase K (Roche). Lysates were then heat-
inactivated for 15 minutes at 95ºC before being used for the genotyping PCR 
reactions. Embryos and fetuses were genotyped by PCR using genomic DNA 
extracted from yolk sacs (embryos), and intestines or skin (fetuses). When yolk 
sacs were used, they were incubated overnight at 55º C in yolk sac lysis buffer 
(50 mM KCl, 10 mM Tris-HCl pH 8.3, 2 mM MgCl2, 0.45% Tween-20, 0.45% 
NP40) containing 200 µg/ml of proteinase K. Lysates were heat-inactivated as 
above. When intestine or skin samples were used, they were incubated 
overnight at 50º C under agitation in Laird's buffer (100 mM Tris-HCl pH 8.5, 5 
mM EDTA, 0.2% SDS, 200 mM NaCl) supplemented with 100 µg/ml of 
proteinase K. Genomic DNA was then precipitated with isopropanol (1:1 vol:vol) 
and transferred to TE buffer (1 mM EDTA, 10 mM Tris-HCl pH8.0). All 
genotyping PCR reactions were performed using 1.5 µl of the genomic DNA 
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solution. All primers used for genotyping are described in the Key Resource 
Table. 
 
Ethics statement 
Experiments involving animals carried out in the Oeiras laboratory followed the 
Portuguese (Portaria 1005/92) and European (Directive 2010/63/EU) 
legislations, concerning housing, husbandry, and welfare. The project was 
reviewed and approved by the Ethics Committee of “Instituto Gulbenkian de 
Ciência” and by the Portuguese National Entity, “Direcção Geral de 
Alimentação Veterinária” (license reference: 014308). Experiments involving 
animals carried out in the Geneva laboratory were performed in agreement with 
the Swiss law on animal protection (LPA), under license No GE 81/14 (to DD). 
 
METHOD DETAIL 
Skeletal analyses 
Skeletal preparations were performed at E18.5 by alcian blue/alizarin red 
staining. Fetuses were obtained by caesarean section, skinned, eviscerated 
and fixed in 100% ethanol at room temperature for at least 12 hours. They were 
stained with alcian blue 8 GX (150 mg/l in 20% acetic acid, 80% ethanol) at 
room temperature for 12 hours and postfixed in 100% ethanol for 12 hours. 
Fetuses were cleared in 2% KOH for 8 hours at room temperature, stained with 
alizarin red S (50 mg/l in 2% KOH) for 2 hours and further cleared in 2% KOH 
for 10 to 16 hours at room temperature. The reaction was stopped with 25% 
glycerol and the stained carcasses stored in the same solution. Caudal 
vertebrae were counted in a minimum of 10 embryos for each condition and 
statistical significance was assessed using non-parametric one-way ANOVA 
with Dunn’s multiple comparison test (alpha=0.05). 
 
Histological analyses 
Embryos were collected by caesarean section, dissected in Dulbecco’s 
Phosphate Buffered Saline (PBS) (1.8 mM KH2PO4, 2.7 mM KCl, 10 mM 
Na2HPO4, 137 mM NaCl) and fixed in Bouin’s fixative (Sigma) for one overnight 
(E10.5) or two days (E18.5). They were then dehydrated thoroughly in ethanol 
100%, washed extensively in toluol and embedded in paraffin. Embryos were 
sectioned at 10 µm with a microtome and stained with haematoxylin and eosin 
according to standard methods. 
 
In situ hybridization 
Whole mount in situ hybridization was performed using in vitro transcribed 
digoxigenin-labelled antisense RNA probes. Briefly, embryos were dissected 
out in PBS and fixed with 4% paraformaldehyde (Sigma) made in PBS (PFA) at 
4ºC overnight. Embryos were washed in PBT (PBS containing 0.1% Tween-20), 
dehydrated with methanol and rehydrated with PBT. They were then treated 
with proteinase K (10 µg/ml in PBT) at room temperature for 9 minutes for 
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E10.5 embryos, 12 minutes for E11.5, 15 min for E12.5 embryos, and 16 min 
for E13.5 embryos. The reaction was stopped with glycine (2 mg/ml in PBT) and 
embryos were postfixed with 4% paraformaldehyde, 0.2% glutaraldehyde 
(Sigma). Hybridization was performed at 70ºC overnight in hybridization solution 
[50% formamide, 1.3 x SSC (3M NaCl, 300 mM sodium citrate, pH 5.5), 5 mM 
EDTA, 0.2 % Tween 20, 50 µg/ml yeast tRNA, 100 µg/ml heparin] containing 
the RNA probe, followed by three washes at 70ºC in hybridization solution 
without the RNA probe, tRNA and heparin. Embryos were then washed in TBST 
(25 mM Tris.HCl, pH 8.0, 140 mM NaCl, 2.7 mM KCl, 0.1% Tween 20), 
equilibrated with MABT (100 mM Maleic acid, 150 mM NaCl, 0.1 % Tween-20, 
pH 7.5), blocked with MABT/Block [MABT containing 1% blocking reagent 
(Roche #11096176001) and 10% sheep serum] for 2-3h and incubated with a 
1:2000 dilution of alkaline phosphatase-conjugated anti-digoxigenin antibody 
(Roche Cat# 11093274910, RRID:AB_514497) in MABT/Block at 4ºC overnight. 
Embryos were washed extensively with MABT at room temperature for 24h, 
equilibrated in NTMT (100 mM Tris HCl, pH 9.5, 50 mM MgCl2, 100 mM NaCl, 
0.1% Tween-20) and developed at room temperature with NBT/BCIP (Roche 
#11681451001) diluted in NTMT, or with BM Purple (Roche #11442074001). 
Reactions were stopped with PBT, fixed with 4% PFA and stored in PBT. 
Probes for Mesogenin1, Hoxb13, Hoxc13, Lin28a and Lin28b were 
prepared by amplifying cDNA fragments and cloning them into appropriate 
vectors for in vitro transcription. The sequences for all used primers can be 
found in the Key Resource Table. 
 
Post-staining embryo sectioning 
To section whole mount-stained embryos, these were included in 
gelatin/albumin [0.45 % gelatin, 270 g/l bovine serum albumin (Roche), 180 g/l 
sucrose in PBS, jellified with 1.75 % glutaraldehyde]. Sections were cut at 35 
µm with a vibratome and mounted with an aqueous mounting solution (Aquatex, 
Merck). Vibratome sections were photographed and used for measuring the 
areas of the neural tube, mesoderm and ectopic epithelial pocket in wild type 
and Gdf11-/- embryonic tails using Fiji (Fiji, RRID: SCR_002285). Two sections 
per tail at the PSM level were used, for a minimum of 10 embryos per condition. 
Statistical significance was assessed using an unpaired t-test using the Holm-
Sidak method (alpha=0.05). 
 
Fluorescence activated cell sorting (FACS)  
Embryos were dissected in PBS and tails were pooled in 10% donkey serum in 
PBS. Tail tips were centrifuged at room temperature for 5 minutes at 1000 rpm 
and incubated on ice for 5 minutes with accutase. Tails were then dissociated 
into a single cell suspension and washed twice with PBS/10% donkey serum 
(Biowest S2170-100). Cells from both wild type and Gdf11 mutant tails were 
counted and equivalent numbers for each condition were blocked for 30 
minutes in 100 µl of blocking solution (10% donkey serum/1:100 Fc block in 
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PBS). Cells were processed for staining using True-Nuclear™ Transcription 
Factor Buffer Set (Biolegend) according to the manufacturer’s instructions. They 
were incubated for 1 hour with primary antibodies against Sox2 (Abcam Cat# 
ab92494, RRID:AB_10585428) and T (R and D Systems Cat# AF2085, 
RRID:AB_2200235), diluted 1:200 in Perm buffer, washed twice in the same 
buffer and incubated for another hour with donkey anti-rabbit A568 (Thermo 
Fisher Scientific Cat# A10042, RRID:AB_2534017) and donkey anti-goat A647 
(Thermo Fisher Scientific Cat# A-21447, RRID:AB_2535864) secondary 
antibodies, diluted 1:1000 in perm buffer. After three washes in perm buffer, 
cells were ressuspended in 300 µl PBS. Data acquisition was performed in a 
LSR Fortessa X20 flow cytometer. Gene expression levels were assessed after 
removing debris on the basis of the forward scatter-area (FSC-A) and side 
scatter signals (SSC-A). Doublets were removed using the FSC-A and forward 
scatter-width (FSC-W) signals. Quadrants were defined according to levels of 
background fluorescence as given by unstained and secondary-only incubated 
cell controls. FACS data was analyzed using FlowJo X software. Quadrant 
averages were calculated using 8 independent experiments. Statistical 
significance was assessed using the non-parametric Mann-Whitney test. 
 
Lineage tracing analyses 
Cre-mediated recombination was induced at E7.5 by a single intraperitoneal 
injection of 200 µl of a 1 mg/ml solution of tamoxifen (Sigma) in corn oil (Sigma). 
Embryos were collected at E10.5 by caesarean section, dissected in PBS and 
processed for β-galactosidase staining. Briefly, embryos were fixed with 4% 
PFA for 30 minutes at room temperature. After 3 washes with washing solution 
(PBS containing 0.02% NP40, 0.02% Tween 20) embryos were incubated at 
37ºC in X-gal staining solution [5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6·3H2O, 2 mM 
MgCl2, 0.02% NP40, 0.02% Tween 20, in PBS, including 0.4 mg/ml X-gal 
(Promega)] and the reaction was monitored regularly. After developing, 
embryos were extensively washed in washing solution, fixed overnight in 
4%PFA and embedded in gelatin/albumin as described above and sectioned 
with a vibratome. β-gal+ cells were counted in 4 (trunk) or 9 (tail) consecutive 
sections using Fiji. The average number of cells per section in each 
compartment (neural tube or mesoderm) was calculated. Three embryos from 
each condition were used for this analysis. Statistical significance was assessed 
through an unpaired t-test using the Holm-Sidak method (alpha=0.05). 
 
Tail explant cultures and serial passaging experiments 
Wild type and Gdf11 mutant embryos were collected in PBS at E10.5, their tails 
dissected and cultured as previously described (Tesar et al., 2007). Briefly, tails 
were severed from the embryo at the level of the last somite and incubated for 5 
minutes in 1x accutase at 4ºC (Sigma, A6964). Tail tips were then washed three 
times with “N2B27 medium”, which was constituted by Dulbecco’s Modified 
Eagle Medium F12 (Gibco) and Neurobasal medium (Gibco) (1:1), 
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supplemented with 0.1 mM 2-mercaptoethanol (Sigma), 2 mM L-glutamine 
(Gibco), 40 mg/ml BSA (Sigma), 1x N2 (Gibco) and 1x B27 (Gibco) (Gouti et al., 
2014). The tissue was mechanically dissociated to obtain 10-100 cell clumps. 
These were plated onto 24-well plates coated with a 50 µg/µl fibronectin 
solution in PBS (Lauschke et al., 2013) with the previously described “N2B27 
medium”, now supplemented with 20 ng/ml bFGF (R&D Systems), 3 µM CHIR 
(Abcam) and with or without 10 µM Alk-receptor inhibitor SB431542 (Abcam). 
Cells were allowed to grow at 37ºC with 5% CO2 and their medium was 
changed every other day. 
Cells were passaged every three days. Cell passaging was performed by 
washing wells twice with PBS, followed by five-minute incubation with accutase 
at RT. Cell suspensions were transferred to N2B27 medium without growth 
factor supplementation, centrifuged for 5 minutes at 1000 rpm, ressuspended in 
500 µl of N2B27 medium and counted. 2x104 cells were passaged onto new 
fibronectin-coated wells in 24-well plates or wells containing fibronectin-coated 
coverslips for immunofluorescence. Cells were grown as described above. 
Growth was plotted as the cumulative Population Doubling Levels (PDL) of four 
independent experiments and was calculated according to the formula PD= log2 
(N2/N1), in which N1 represents the number of seeded cells and N2 the total 
number of cells obtained at the time of passaging. Statistical significance of the 
PDL in each time point for the set of 4 experiments was assessed using a two-
way ANOVA where p<0.05 was considered significant. Linear regression was 
performed to calculate PDL growth ratio and the proliferation time was 
calculated by finding the inverse of this ratio (PDT=1/PDL). The PDL growth 
ratios obtained by linear regression were the following (expressed as 
doublings/day): WT- 0.42; WT+SB – 1.16, Gdf11 – 0.83, Gdf11+SB – 1.36. 
Statistical significance for the slopes was assessed using a non-parametric one-
way ANOVA with Dunn’s multiple comparison test (alpha=0.05). 
	  
Imunofluorescence  
Immunofluorescence was performed on cultured cell explants or cryostat 
sections of embryos. Coverslips with attached explant cells were washed twice 
in PBS, fixed in 4% PFA for 15 minutes at room temperature and rinsed three 
times in PBS. After permeabilization in PBS 0.3% Triton-X for 15 minutes, cells 
were blocked for 1 hour in blocking solution (PBS/10% serum). Primary 
antibodies were diluted in blocking solution and incubated overnight at 4ºC. 
After three washes with PBS, slides were incubated with secondary antibodies 
diluted 1:1000 in blocking solution for 3-4 hours at room temperature. After 
extensive washing with PBS, nuclei were counterstained with 4’, 6-Diamidino-2-
Phenylindole Dilactate (DAPI) (Thermo Fisher Scientific Cat# D3571, RRID: 
AB_2307445) (1:1000 in PBS) and mounted in glass slides. 
For immunofluorescence staining of tail tissues, after an overnight 
fixation with 4% PFA, embryos were washed thoroughly in PBS and incubated 
overnight at 4ºC in 15% sucrose (Sigma) in PBS and equilibrated with 15% 
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sucrose/7% gelatin (Sigma) in PBS for 2-6 hours at 37ºC. They were then 
transferred to appropriate moulds and frozen in liquid nitrogen. 14 µm-thick 
sagittal sections were obtained using a cryostat and adjacent sections collected 
in duplicate slides. For immunofluorescence, tissues were de-gelatinized, 
permeabilized with 0.1% Triton-X in PBS for 15 minutes and extensively 
washed with PBS. Sections were blocked in a 3% donkey serum (Biowest 
S2170-100)/1% BSA (Roche #10735086001) solution in PBST for 1 hour at 
room temperature. Primary antibodies were diluted in blocking solution and 
incubated overnight at 4ºC. Secondary antibodies were diluted in 1:1000 in 
blocking buffer and incubated for 3-4h at room temperature. After washes in 
PBS, slides were stained with DAPI (1:1000 in PBS) for 5 minutes. 
The following primary antibodies were used in these experiments: goat 
anti-Brachyury (R and D Systems Cat# AF2085, RRID:AB_2200235; 1:250), 
mouse anti-Hoxb13 (Santa Cruz Biotechnology Cat# sc-28333, 
RRID:AB_627744; 1:100), mouse anti-Hoxc13 (sc-514377, Santa Cruz 
Biotechnology; 1:100), mouse anti-Nestin (Abcam Cat# ab6142, 
RRID:AB_305313; 1:250), goat anti-Lin28a (R and D Systems Cat# AF3757, 
RRID:AB_2234537; 1:200), goat anti-Tbx6 (R and D Systems Cat# AF4744, 
RRID:AB_2200834; 1:100), rabbit anti-Sox2 (Abcam Cat# ab92494, 
RRID:AB_10585428; 1:250), rabbit anti-Tuj1 (Abcam Cat# ab18207, 
RRID:AB_444319, 1:250). The secondary antibodies were: donkey anti-mouse 
Alexa 488 (Abcam Cat# ab150105, RRID:AB_2732856), donkey anti-goat Alexa 
Fluor 488 (Thermo Fisher Scientific Cat# A-11055, RRID:AB_2534102), donkey 
anti-goat Alexa Fluor 647 (Thermo Fisher Scientific Cat# A-21447, 
RRID:AB_2535864), and  Alexa fluor 568 donkey anti-rabbit (Thermo Fisher 
Scientific Cat# A10042, RRID:AB_2534017). 
Slides and tissue sections were mounted using VectaShield® (Vector 
Laboratories Cat# H-1000, RRID:AB_2336789). Confocal Z-series stacks of 
immunostained material were acquired on a Leica SP5 confocal microscope 
(Leica SP5 live; Leica Microsystems) using a 20x objective. Images were 
processed using Fiji software (NIH). A minimum of 10 images (optical sections) 
were used for each maximum projection Z-stack. 
 
Apoptosis and proliferation analysis 
Cell apoptosis was assessed using in situ cell death detection kit, fluorescein 
(#11684795910, Roche). Briefly, cryosectioned tissue was de-gelatinized, 
permeabilized and blocked as previously described for immunofluorescence. 
Primary antibodies for phospho-Histone 3 (Millipore Cat# 06-570, 
RRID:AB_310177) and Sox2 (Santa Cruz Biotechnology Cat# sc-17320, 
RRID:AB_2286684) were incubated 1:200 overnight in blocking solution. After 
rinsing three times in PBS, slides were incubated with 0.1% Triton-X in 0.1% 
sodium citrate for 2 minutes on ice, washed again and incubated for 1 hour with 
50µl of TUNEL reaction mixture prepared according to the manufacturer’s 
instructions. Tissue sections were then incubated 3-4h in secondary antibodies 
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donkey anti-goat Alexa Fluor 647 (Thermo Fisher Scientific Cat# A-21447, 
RRID:AB_2535864) and  donkey anti-rabbit Alexa fluor 568 (Thermo Fisher 
Scientific Cat# A10042, RRID:AB_2534017) diluted 1:1000 in blocking solution. 
After extensive washes in PBS, samples were incubated with DAPI (1:1000 in 
PBS), mounted in Vectashield and imaged. Two to 6 sections from tails of 3 
embryos from each condition were used. pH3 positive cells in each 
compartment were counted using Fiji and statistical significance was assessed 
using unpaired t-test using the Holm-Sidak method (alpha=0.05). 
 
RNAseq 
Total RNA was isolated from at least 8 tail buds obtained from E10.5 wild type 
and Gdf11 mutant embryos using the RNeasy mini kit (Qiagen), according the 
manufacture’s recommendations. The RNA quantity and purity were measured 
with a Nanodrop ND-100 spectrophotometer (Thermo Scientific). RNA integrity 
number (RIN) was determined with the AATI Fragment Analyzer. RNA-seq 
libraries from two biological replicates from each condition were prepared using 
TrueSeq stranded mRNA sample Prep Kit and sequenced using Illumina Hiseq 
2500 system, to obtain 50 base single-end reads at CRG Genomics Unit 
(Barcelona, Spain). At least, 25 M of SE reads were generated for each library 
in a sequencing lane. Read alignments were made using Tophat2 v2.0.9 (Kim 
et al. 2013) with Bowtie v2.1.0.0 (Langmead and Salzberg, 2012). Differential 
expression analysis between wild type and Gdf11 mutant samples was 
performed using CuffDiff v2.1.1 (Trapnell et al., 2013). Genes with FDR<0.05 
were considered to be differentially expressed. 
Gene Ontology (GO) analysis (Eden et al., 2009, 2007) was used to 
identify enriched GO process terms using a list of the top 88 genes that 
exhibited a log2Foldchange > 2 and q value < 0.005 in Gdf11-/- comparing to the 
WT.  
 
RT-qPCR  
Total RNA was extracted from cultured cells using Tri Reagent (Sigma) 
according to the manufacture’s protocol, and resuspended in water. The total 
RNA concentration was determined with a Nanodrop ND-100 
spectrophotometer. 1 ug of RNA was reverse-transcribed into complementary 
DNA (cDNA) using a random hexamer mix (NZYTech) and following the 
protocol of the NZY Reverse Transcriptase enzyme (NZYTech). Real-time PCR 
was performed with iQ SYBR Green Supermix (Bio-rad) according to 
manufacturer’s instructions and using CFX384 Real Time PCR Detection 
System (Bio-Rad). Primers are listed in the Key Resource Table. The 
expression levels were normalized to β-Actin and changes in fold expression 
were calculated using the ΔΔCt method. Gene expression data was presented 
as the mean ± SD. Differences were considered significant at *p<0.05, ** 
p<0.01, and ***p<0.001. Statistical significance was assessed using the non-
parametric Mann-Whitney test.	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IMAGE PROCESSING AND ANALYSIS 
All image processing, analysis and measurements were performed using Fiji 
(Fiji, RRID:SCR_002285). Data was analyzed and plotted using GraphPad 
Prism7 (Graphpad Prism, RRID:SCR_002798). 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
The quantitation and statistical analyses associated with the different 
experimental procedures included in this paper are described in the 
corresponding subsections of the Method Details. Tail length analysis and 
comparison between wild type and Lin28 transgenics is described at the end of 
the skeletal analysis subsection. The method used to calculate the progenitor 
cell number in the tail buds by FACS is specified at the end of the fluorescence 
activated cell sorting (FACS) subsection. The analysis of labelled progenitor 
contribution to different areas of the trunk and tail tissues is described at the 
end of the Lineage tracing analyses subsection. Details on the in vitro growth 
properties of explanted tail bud cells can be found at the end of the Tail explant 
cultures and serial passaging experiments subsection. The methods used for 
transcript quantification and content comparison between wild type and Gdf11 
mutant embryos by RNA-seq and qPCR are specified at the end of the 
subsections where the experimental details of these procedures are described. 
 
DATA AVAILABILITY 
The raw sequencing data of the RNA-seq experiments was deposited in the 
NCBI trace and Short-read Archive (SRA), accession number SRP167717 
(https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP167717&go=go). 
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FIGURES 
 
 
 
Figure 1. Gdf11 mutant embryos exhibit tail malformations. A. Skeletal (a, b, d, e) and 
histological (c, f) analysis of E18.5 wild type (WT; a-c) and Gdf11 mutant fetuses (Gdf11-/-; d-f). 
Insets in b) and e) show dissected vertebrae at the indicated axial level. Black arrowheads 
indicate the caudal end of the neural tube. B. E10.5 wild type (a-c) and Gdf11-/- (d-f) embryos, 
as whole mount view (a, d) or in DAPI staining of sagittal (b, e) or transversal (c, f) sections 
through the tail. Dotted lines in a and d delimit and emphasize tail morphology. Dotted lines in b 
and e indicate the levels of the sections in c and f. NT, neural tube; No, notochord; Gt, gut; Me, 
mesoderm; the asterisk indicates the ectopic ventral epithelial pocket characteristic of Gdf11 
mutant tails. Scale bars: 100µm. C. Total area of transversal sections of wild type and Gdf11-/- 
tail buds at the level of the PSM (*** p<0.001). D. Total areas of the main tissue compartments 
in wild type and Gdf11-/- tail buds at the level of the PSM (**p<0.01, **** p<0.0001). Error bars 
indicate the standard deviation (SD). 
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Figure 2. FACS analysis of Sox2 and T(Bra) expression in wild type and Gdf11-/- tail buds. 
A. Representative pseudo-color dot plots depicting the distribution of events and quadrants in 
wild type and Gdf11-/- tail buds. B. Proportion of cells co-expressing Sox2 and T (Bra) (quadrant 
2 in the plots), or T (quadrant 1 in the plots) and Sox2 (quadrant 3 in the plots) alone in wild type 
and Gdf11-/- tail buds from 8 independent experiments (*p<0.05; **p<0.001). Error bars indicate 
the SD.	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Figure 3. Lineage tracing analysis and proliferation in wild type and Gdf11-/- tail buds. A. 
β-gal staining of E10.5 wild type (a-a’’) and Gdf11-/- (b-b’’) embryos. a and b show whole mount 
views; a’ and b’ show sections at trunk levels; and a’’ and b’’ show sections at tail levels. Dotted 
lines in a and b indicate the levels of the sections. B. Differential contribution of β-gal+ cells to 
neural tube and mesoderm in the embryonic trunk and tail expressed as the ratio between 
stained cells in each compartment at the respective axial level (***p<0.001). C. Relative 
enrichment of β-gal+ cells in neural tube and mesoderm in the tail bud compared to the trunk. D. 
Distribution of β-gal+ cells in the different tissue compartments in the tail bud (*p<0.05). E. 
Immunofluorescence for Sox2 and pH3 in sagittal sections of wild type and Gdf11-/- tail buds. F. 
Quantification of cell proliferation in the neural tube and mesoderm of wild type and Gdf11-/- tail 
buds (*p<0.05). Each dot represents one independent experiment. Error bars indicate the SD 
from three independent experiments. 
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Figure 4. Culture of tail bud explants in the presence and absence of Gdf11 signalling. A. 
Growth as cumulative population doubling (CPD) and corresponding growth rates in cultures of 
E10.5 wild type and Gdf11-/- tail bud explants in the presence (+SB) or absence of the TGF-β 
inhibitor SB431542, subjected to serial passaging (every 3 days). Error bars indicate the SD of 
four independent experiments. B. Gene expression analysis by qRT-PCR for Sox2, TujI, T(Bra) 
and Tbx6 in cultured tail bud explants 3 (D3), 6 (D6) and 9 (D9) days after plating. Expression in 
D3 wild type cells was used as the reference to represent relative expression levels obtained in 
each culture condition of the same time point (*p<0.05, **p<0.01). Error bars indicate the SD of 
six independent experiments. C. Immunofluorescence images of tail bud explants stained for 
Sox2 and T(Bra), or Sox2 and TujI at D3, D6 and D9 after seeding. Scale bars: 100µm. 
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Figure 5. RNAseq analysis and validation in E10.5 and E11.5 wild type and Gdf11-/- 
embryonic tails. A. Fold change differences of representative neural (blue), mesodermal 
(pink), and Hox (green) genes between wild type and Gdf11-/- E 10.5 embryos. B. Whole mount 
in situ hybridization of wild type (a-d, i-l) and Gdf11-/- (e-h, m-p) embryos at E10.5 (a-h) or E11.5 
(i-p) using probes for Lin28a (a, e, i, m), Lin28b (b, f, j, n), Hoxb13 (c, g, k, o), and Hoxc13 (d, h, 
l, p). Insets show dorsal views of the tail bud. Tail shapes are delimited by dotted lines. C. 
Skeletal preparations of tails from E18.5 wild type (a), Cdx2-Lin28a (b), Cdx2-Lin28b (c), and 
compound Cdx2-Lin28a + Cdx2-Lin28b (Cdx2-Lin28a+b) (d) fetuses. D. Number of caudal 
vertebrae in wild type, Cdx2-Lin28a, Cdx2-Lin28b, and Cdx2-Lin28a+b transgenic fetuses 
(*p<0.05, **p<0.01, ****p<0.0001). Each dot represents an individual specimen. Error bars 
indicate the SD. E. Dorsal view of whole mount in situ hybridization of E13.5 tails from wild type 
(a, d), Cdx2-Lin28a (b, e), and Cdx2-Lin28b (c, f) embryos using probes for Sox2 (a-c) and 
T(Bra) (d-f).	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Figure 6. Hoxb13 and Hoxc13 overexpression specifically affects tail growth. A-C. Skeletal 
preparations of E18.5 wild type (A), Cdx2-Hoxb13 (B) and Cdx2-Hoxc13 (C) fetuses. D-L. 
Whole mount in situ hybridization of E10.5 wild type (D, G, J), Cdx2-Hoxb13 (E, H, K), and 
Cdx2-Hoxc13 (F, I, L) embryos with probes for T(Bra) (D-F), Sox2 (G-I) and Lin28a (J-L). Insets 
show dorsal views of the tail. Dotted lines indicate the level of the sections displayed in O-R. M 
and N. Whole mount in situ hybridization on E10.5 wild type (M) or HoxCΔ (N) embryos with a 
probe for Lin28a. Insets show a dorsal view of the tail. O-R. Analysis of proliferation (pH3) and 
apoptosis (TUNEL) in transversal tail sections of E10.5 wild type (O, Q) and Cdx2-Hoxb13 (P, 
R) embryos. Insets depict a close-up of the neural tube (stained with Sox2). White arrowheads 
indicate cell death in the neural tube. The asterisk indicates blood accumulation. Scale bar: 
100µm. S. Quantification of cell proliferation in the neural tube and mesoderm of wild type and 
Cdx2-Hoxb13 tails (*p<0.05). Error bars indicate the SD from three independent experiments.	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Figure 7. Gdf11 signalling controls expression of Lin28 genes, Hoxb13 and Hoxc13 in tail 
bud explant cultures. A. qRT-qPCR analysis of Lin28a, Lin28b, Hoxb13, and Hoxc13 
expression in explant cultures at D3 and D6. Expression in D3 wild type cells was used as the 
reference to represent relative expression levels obtained in each culture condition of the same 
time point (*p<0.05, **p<0.01). Error bars indicate the SD of six independent experiments. B. 
Immunofluorescence images of tail bud explants stained for Sox2 and Lin28a, or Sox2 and 
Hoxc13 at day 3 (D3) or day 6 (D6) after seeding. Scale bars: 100µm.	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Figure S1. Related to Figure 3. Gene expression in E10.5 wild type and Gdf11-/- embryonic 
tails. A. Immunofluorescence images of sagittal (a, b) and transversal (a’, b’) sections of wild 
type (a, a’) and Gdf11-/- (b, b’) tail buds stained for Sox2 and T(Bra). Dotted lines indicate the 
level of transversal sections in a’ and b’. White arrowhead indicates the ectopic epithelial pocket 
in Gdf11-/- tails. B. Whole mount in situ hybridization in wild type (a, a’) and Gdf11-/- (b, b’) tail 
buds using a probe for Tbx6. Dotted white lines indicate the level of the transversal sections 
shown in a’ and b’. C. Whole mount in situ hybridization in wild type (a, a’) and Gdf11-/- (b, b’) 
tail buds using a probe for Mesogenin1. Dotted white lines indicate the level of the transversal 
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sections shown in a’ and b’. Insets show dorsal views of the tail. Grey lines and grey dotted 
lines depict the contours of each section and the neural tube, respectively. Black arrowheads 
indicate the ectopic epithelial pocket. D. Whole mount in situ hybridization in three wild type (a, 
c, e; a’’, c’’,e’’) and three Gdf11-/- (b, d, f; b’, d’, f’) E10.5 tails using a probe for Lunatic fringe 
(Lfng). a-f lateral views, a’-f’ dorsal views of each corresponding tail bud. 
  
	   43	  
 
 
	   44	  
Figure S2. Related to Figure 4. Culture of tail bud explants in the presence and absence 
of Gdf11 signaling. A. RT-qPCR analysis of Nestin and Mesogenin1 (Msgn1) expression in 
explant cultures at day 3 (D3), day 6 (D6), and day 9 (D9) after seeding. Expression in D3 wild 
type cells was used as the reference to represent relative expression levels obtained in each 
culture condition of the same time point (*p<0.05, **p<0.01). Error bars indicate the SD of six 
independent experiments. n.d. expression not detected . B. Immunofluorescence images of tail 
bud explants stained for Sox2 and Nestin, or for Sox2 and Tbx6 at the indicated days after 
seeding. Scale bars: 100µm.  
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Figure S3. Related to Figure 5. RNA-seq analysis and validation. A. Enrichment analysis of 
Gene Ontology (GO) terms of 88 genes with a minimum of 2-fold expression change in Gdf11-/- 
vs wild type tail buds. B. Expression levels of 7 genes assessed by RT-qPCR in E10.5 wild type 
and Gdf11 mutant tail buds compared with the data from the RNA-seq datasets. C. Fold change 
differences of relevant metabolic genes between wild type and Gdf11-/- embryos. D. Whole 
mount in situ hybridization in wild type (a, c) and Gdf11-/- (b, d) embryos at E10.5 (a, b) or E11.5 
(c, d) using a probe for Sox10. Insets show a dorsal view of the tail bud. Dotted lines delimit tail 
shape. E. Transversal sections of whole mount in situ hybridization of wild type (a, c) and Gdf11-
/-  (b, d) embryos at E10.5 (a, b) and E11.5 (c, d) using a probe for Lin28a. Black arrowheads 
indicate the ectopic epithelial pocket. 
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Figure S4. Related to Figure 7. Gdf11 signaling controls the expression of Hoxb13 in tail 
bud explant cultures. Immunofluorescence images of tail bud explants stained for Hoxb13 at 
D3 and D6 after plating. Scale bars: 100µm.  
	  
 
	  
Table S1. Related to Figure 5. Comparison of transcript contents in tail buds of 
E10.5 wild type and Gdf11 mutant embryos. 
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Mouse monoclonal anti Hoxb13 Santa Cruz 
Biotechnology  
Cat# sc-28333; 
RRID:AB_627744 
Mouse monoclonal anti Hoxc13 Santa Cruz 
Biotechnology  
Cat# sc-514377 
Goat polyclonal anti Lin28a R & D Systems  Cat# AF3757; 
RRID:AB_2234537 
Mouse monoclonal anti Nestin Abcam  Cat# ab6142; 
RRID:AB_305313 
Goat polyclonal anti Sox2  Santa Cruz 
Biotechnology  
Cat# sc-17320; 
RRID:AB_2286684 
Rabbit polyclonal anti Sox2  Abcam  Cat# ab92494; 
RRID:AB_10585428 
Goat plyclonal anti T(Bra) R & D Systems  Cat# AF2085; 
RRID:AB_2200235 
Goat polyclonal anti Tbx6 R & D Systems  Cat# AF4744; 
RRID:AB_2200834 
Rabbit polyclonal Tujl Abcam  Cat# ab18207 
RRID:AB_444319 
Donkey anti-goat A488 Thermo Fisher 
Scientific  
Cat# A-11055; 
RRID:AB_2534102 
Donkey anti-goat A647 Thermo Fisher 
Scientific  
Cat# A-21447; 
RRID:AB_2535864 
Donkey anti-mouse A488 Abcam  Cat# ab150105; 
RRID:AB_2732856 
Donkey anti-rabbit A568 Thermo Fisher 
Scientific  
Cat# A10042; 
RRID:AB_2534017 
Rabbit polyclonal anti phospho-Histone 3 Millipore Cat# 06-570; 
RRID:AB_310177 
Chemicals, Peptides, and Recombinant Proteins 
DAPI Thermo Fisher 
Scientific Cat# D3571 
RRID: AB_2307445 
SB431542 Abcam Cat # ab120163 
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Critical Commercial Assays 
In situ cell death kit (TUNEL) Roche Cat #11684795910 
True-Nuclear™ Transcription Factor Buffer Set BioLegend Cat #424401 
Deposited Data 
RNA-seq data NCBI trace and Short-
read Archive, 
accession number 
SRP167717 
N/A 
Experimental Models: Organisms/Strains 
Mouse B6;129sv-Gdf11<tm1Sjl> McPherron et al. 1999 RRID:MGI:3589479 
Mouse B6;129S-Hoxc<tm1Nogu> 
 
Suemori and Noguchi, 
2000 
MGI:3640654 
 
Mouse FVB-­‐Tg(Cdx2-­‐creERT) Jurberg et al, 2013 N/A 
Mouse FVB.129S4(B6)-Gt(ROSA)26Sor<tm1Sor>/J Jackson Labs Stock No: 09427 
Oligonucleotides 
Hoxb13-cDNA-Fwd:  
CTCGGCTCCCCATGAGCCGATC 
This paper N/A 
Hoxb13-cDNA-Rev:  
GCCGAGTCCTCTGCCAGTCC 
This paper N/A 
Lin28a-cDNA-Fwd:  
ATGGGCTCGGTGTCCAACCAGC 
This paper N/A 
Lin28a-cDNA-Rev:  
TCAATTCTGGGCTTCTGGGAGC 
This paper N/A 
Lin28b-cDNA-Fwd:  
ATGGCCGAAGGCGGGGCAAGC 
This paper N/A 
Lin28b-cDNA-Rev:  
CTAAGTCTTTTTCCGTTTCTG 
This paper N/A 
Mesogenin1-cDNA-Fwd: 
CCAGGAGTCCCCCACTCAAAG 
This paper N/A 
Mesogenin1-cDNA-Rev: 
CAGGTAATTCCGGAGCGTGTG 
This paper N/A 
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Gdf11-genotyping-Fwd: 
GCATCCTTTCATGGAGCTTCG 
Jurberg et al 2013 N/A 
Gdf11-genotyping-WT-Rev: 
CTGCTGCACCCCTACCAAGATG 
Jurberg et al 2013 N/A 
Gdf11-genotyping-MUT-Rev: 
AAAGAACGGAGCCGGTTGG 
Jurberg et al 2013 N/A 
β-gal-genotyping-Fwd: 
AGCAGTTTTTCCAGTTCCGTTTATC 
This paper N/A 
β-gal -genotyping-Rev: 
AGCGGCGTCAGAAGTTGTTTTTTAT 
This paper N/A 
Cre-ERT-genotyping-Fwd: 
CGAGTGATGAGGTTCGCAAG 
This paper N/A 
CreERT-genotyping-Rev: 
CCTGATCCTGGCAATTTCGGCT 
This paper N/A 
Hoxb13-genotyping-Fwd: 
ATTCTCTGCTTCCCGTGGAC 
This paper N/A 
Hoxb13-genotyping-Rev:  
ATCTTGCGCCTCTTGTCCTT 
This paper N/A 
Hoxc13-genotyping-Fwd: 
GCCAGCTCCTACCAGGCGATG 
This paper N/A 
Hoxc13-genotyping-Rev: 
CTCTAGCTCCTTCAGCTGCAC 
This paper N/A 
Lin28a-genotyping-Fwd: 
ATGGGCTCGGTGTCCAACCAGC 
This paper N/A 
Lin28a-genotyping-Rev: 
TCAATTCTGGGCTTCTGGGAGC 
This paper N/A 
Lin28b-genotyping-Fwd: 
GAGACGGCAGGATTTACTGATGG 
This paper N/A 
Lin28b-genotyping-Rev:  
CTAAGTCTTTTTCCGTTTCTG 
This paper N/A 
Hoxb13-ISH probe-Fwd: 
AGCCCAGTGTCCAGCACCCTC 
This paper N/A 
Hoxb13-ISH probe-Rev: 
TCACAATCAGCTCAACTCATG 
This paper N/A 
Hoxc13-ISH probe-Fwd: 
CTCCCGCACCCTGTATTGG 
This paper N/A 
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Hoxc13-ISH probe-Rev: 
GCCGGTAGCTGCTCACTTCG 
This paper N/A 
Lin28a-ISH probe-Fwd: 
ATGGGCTCGGTGTCCAACCAGC 
This paper N/A 
Lin28a-ISH probe-Rev: 
TCAATTCTGGGCTTCTGGGAGC 
This paper N/A 
Lin28b-ISH probe-Fwd: 
GAGACGGCAGGATTTACTGATGG 
This paper N/A 
Lin28b-ISH probe-Rev: 
CTAAGTCTTTTTCCGTTTCTG 
This paper N/A 
Sox2-qPCR-Fwd: 
TTTGTCCGAGACCGAGAAGC 
This paper N/A 
Sox2-qPCR-Rev: 
CTCCGGGAAGCGTGTACTTA 
This paper N/A 
T-qPCR-Fwd: 
ACCCAGCTCTAAGGAACCAC 
This paper N/A 
T-qPCR-Rev: 
GCTGGCGTTATGACTCACAG 
This paper N/A 
Hoxb13-qPCR-Fwd: 
ATTCTCTGCTTCCCGTGGAC 
This paper N/A 
Hoxb13-qPCR-Rev: 
ATCTTGCGCCTCTTGTCCTT 
This paper N/A 
Hoxc13-qPCR-Fwd: 
AGCACTGGGCTCTTTCCAAT 
This paper N/A 
Hoxc13-qPCR-Rev: 
CTGTAGAGGAACCACGTCTGG 
This paper N/A 
Lin28a-qPCR-Fwd: 
CAACCAGCAGTTTGCAGGTGGCT 
This paper N/A 
Lin28a-qPCR-Rev: 
CCGAACCCCATGCGCACGTT 
This paper N/A 
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Lin28b-qPCR-Fwd: 
CAAAGGGAGATAGGTGGAGA 
This paper N/A 
Lin28b-qPCR-Rev: 
GATTCTGCCTCCTGTCTTCC 
This paper N/A 
Msgn1-qPCR-Fwd: 
AGGTAATTCCGGAGCGTGTG 
This paper N/A 
Msgn1-qPCR-Rev: 
TCAAGATGTCTGTCCAGCGG 
This paper N/A 
Tbx6-qPCR-Fwd: 
CACCTTGATTTCACTCCACCC 
This paper N/A 
Tbx6-qPCR-Rev: 
TCCCTCCATTCGCACTAAGG 
This paper N/A 
Nestin-qPCR-Fwd: 
GGGAGATCGCTTAGAGGTG 
This paper N/A 
Nestin-qPCR-Rev: 
ACAGCCAGCTGGAACTTTTC 
This paper N/A 
Tubb3-qPCR-Fwd: 
TGAGGCCTCCTCTCACAAGTA 
This paper N/A 
Tubb3-qPCR-Rev: 
CCGCACGACATCTAGGACTG 
This paper N/A 
Pou5f1-qPCR-Fwd: 
AAGTGGGTGGAGGAAGCCGAC 
This paper N/A 
Pou5f1-qPCR-Rev: 
GGTGTCCCTGTAGCCTCATACTC 
This paper N/A 
β-Actin-qPCR-Fwd: 
ATGAAGATCCTGACCGAGCG 
This paper N/A 
β-Actin-qPCR-Rev: 
TACTTGCGCTCAGGAGGAGC 
This paper N/A 
Recombinant DNA 
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Cdx2-Lin28a transgenic construct This paper N/A 
Cdx2-Lin28b transgenic construct This paper N/A 
Cdx2-Hoxb13 transgenic construct This paper N/A 
Cdx2-Hoxc13 transgenic construct Young et al 2009 N/A 
Hoxb13-ISH-probe This paper N/A 
Hoxc13-ISH-probe This paper N/A 
Lin28a-ISH-probe This paper N/A 
Lin28b-ISH-probe This paper N/A 
Msgn1-ISH-probe This paper N/A 
Sox10-ISH-probe Britsch et al., 2001 N/A 
Sox2-ISH-probe Aires et al., 2016 N/A 
T(Bra)-ISH-probe Aires et al., 2016 N/A 
Tbx6-ISH-probe Hofmann et al., 2004 N/A 
Lfng-ISH-probe Casaca et al, 2016 N/A 
Software and Algorithms 
Fiji Fiji RRID:SCR_002285 
GraphPad Prism7 Graphpad Prism RRID:SCR_002798 
FlowJo  FlowJo LLC RRID:SCR_008520 
Other 
VectaShield® Vector Laboratories 
Cat# H-1000 
RRID:AB_2336789 
 
	  
